Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 310

Results For "EU"

5722 News Found

Granules India received ANDA approval for Sildenafil for oral suspension
Drug Approval | December 06, 2023

Granules India received ANDA approval for Sildenafil for oral suspension

The current annual U.S. market for Sildenafil for Oral Suspension is approximately $43 million


Briefs: Shelter Pharma and GMM Pfaudler
News | December 06, 2023

Briefs: Shelter Pharma and GMM Pfaudler

GMM Pfaudler US completes acquisition of MixPro


AstraZeneca discontinues Phase III trials of Stabilizer-CKD and Dialize-Outcomes
News | December 05, 2023

AstraZeneca discontinues Phase III trials of Stabilizer-CKD and Dialize-Outcomes

STABILIZE-CKD and DIALIZE-Outcomes trials are part of the CRYSTALIZE evidence programme


Ashland launches Perfectyl to rock skin perfection without injection
Biotech | December 04, 2023

Ashland launches Perfectyl to rock skin perfection without injection

Multi-ethnic innovation helps all complexions appear clearer and more uniform


AstraZeneca Pharma India receives permission from CDSCO to import new drug
Drug Approval | December 04, 2023

AstraZeneca Pharma India receives permission from CDSCO to import new drug

The receipt of this permission paves way for the launch of BREZTRI AEROSPHERE in India


Venus Remedies granted market authorizations in Saudi Arabia and Philippines
News | December 02, 2023

Venus Remedies granted market authorizations in Saudi Arabia and Philippines

These regulatory approvals signify a significant milestone for Venus Remedies Limited


AstraZeneca Pharma appoints Venkat Natarajan as Lead - Market Access
People | December 02, 2023

AstraZeneca Pharma appoints Venkat Natarajan as Lead - Market Access

Currently, Venkat is Lead – Market Access, India at Pfizer


Lupin launches Turqoz (Norgestrel and Ethinyl Estradiol) Tablets in US
Drug Approval | December 02, 2023

Lupin launches Turqoz (Norgestrel and Ethinyl Estradiol) Tablets in US

Norgestrel and Ethinyl Estradiol Tablets USP (RLD: Lo/Ovral-28) had estimated annual sales of US $33 million in the US


Strides launches Icosapent Ethyl Acid Soft Gel capsules in partnership with Amneal
News | December 02, 2023

Strides launches Icosapent Ethyl Acid Soft Gel capsules in partnership with Amneal

The product has been in-licensed from Strides and will be commercialized by Amneal


Biocon Biologics completes Integration of Viatris' Biosimilar business
News | December 01, 2023

Biocon Biologics completes Integration of Viatris' Biosimilar business

The full transition of Viatris' biosimilars operations to Biocon Biologics in Europe represents another significant milestone